Last reviewed · How we verify
NCT06261372
Mindfulness Meditation Combined With Progressive Muscle Relaxation Training for Uremic Sarcopenia
NA trial testing The mindfulness meditation combined with progressive muscle relaxation training . in Hemodialysis Patients With Sarcopenia in 49 participants. Completed in 15 November 2023.
15 November 2023
Quick facts
| Lead sponsor | Ningbo Medical Center Lihuili Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 49 |
| Start date | 15 August 2023 |
| Primary completion | 15 November 2023 |
| Estimated completion | 15 November 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- The mindfulness meditation combined with progressive muscle relaxation training .
Conditions studied
- Hemodialysis Patients With Sarcopenia — all drugs for Hemodialysis Patients With Sarcopenia →
Sponsor
Ningbo Medical Center Lihuili Hospital
Who can join
Adults 18 to 80, any sex, with Hemodialysis Patients With Sarcopenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To study the effect of mindfulness meditation combined with progressive muscle relaxation training on clinical efficacy and quality of life in maintenance hemodialysis (MHD) patients with sarcopenia. Eligible sarcopenic patients in our hospital were randomly assigned to a control group (n = 24) and an intervention group (n = 25). The control group received conventional dialysis treatment, while the intervention group received mindfulness meditation combined with progressive muscle relaxation training during the interdialysis period in addition to conventional dialysis treatment. The effect of the intervention was evaluated after 12 weeks.To observe whether the combined intervention training can improve the motor ability and quality of life of patients with sarcopenia in a short period of time.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The influence of mindfulness meditation combined with progressive muscle relaxation training on the clinical efficacy and quality of life of patients with sarcopenia receiving haemodialysis: a randomised controlled trial.
Wu YY, Gao YY, Wang JQ, Zhang C, et al · · 2024 · cited 7× · PMID 38760722 · DOI 10.1186/s12906-024-04485-3 -
Effects of mindfulness meditation combined with progressive muscle relaxation on sleep disorders, anxiety, and depression in patients with sarcopenia undergoing hemodialysis.
Wu Y, Zhang H, Jiang L, Liu Z, et al · · 2025 · cited 2× · PMID 40585548 · DOI 10.3389/fpsyt.2025.1542028
Verify or expand the search:
- PubMed search for NCT06261372
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ningbo Medical Center Lihuili Hospital trials
Trials by the same sponsor.
- NCT07572708 — Transcutaneous Electrical Acustimulation (TEA) for the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD) · NA · not yet recruiting
- NCT07368023 — A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoin · not yet recruiting
- NCT07273032 — Clinical Application Research of Combined Therapy in ERAS for Accelerated Orthopedic Rehabilitation · Phase 4 · not yet recruiting
- NCT07310836 — A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoin · not yet recruiting
- NCT06982664 — Effect of Preserving the Left Colic Artery on Proximal Bowel Perfusion · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06261372 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ningbo Medical Center Lihuili Hospital
- Last refreshed: 15 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06261372.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing